News

The partnerships come in the wake of an eight-year legal battle in which IQVIA accused Veeva of stealing trade secrets.

Lee Kim, HIMSS senior principal of cybersecurity and privacy, spoke with MobiHealthNews about GPT-5 use in healthcare. She emphasized that patient safety and cybersecurity must remain top priorities for developers.

The acquisition expands Teladoc's specialist network and presence in the region, while the company navigates ongoing financial challenges.

CredAlliance aims to eliminate duplication of the credentialing process for providers.

ArteraAI Prostate uses digital pathology images from a patient’s biopsy to predict potential long-term outcomes of their prostate cancer.

The companies will develop AI models trained on real-world data to help identify and diagnose patients with paroxysmal nocturnal hemoglobinuria.

ArteraAI Prostate forecasts potential long-term outcomes of a patient's prostate cancer biopsy slide based on digital pathology images.

The financing comes on top of the company's $900 million annual research and development investment in the U.S.

The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.

The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combating the FDA’s claim that it qualifies as a regulated medical device.